Q3 2018
Released Nov 8, 2018, after the close
10-Q filed Nov 8, 2018, 39 days after period end · 0001493152-18-015466
Q3 2018 · 10-Q
Revenue$1.72M$1.72M +88.2% vs Q3 2017+26.2% vs Q2 2018
Net Income-$566.00K-$566.00K N/M vs Q3 2017N/M vs Q2 2018
EPS Diluted-$0.08-$0.08 N/M vs Q3 2017N/M vs Q2 2018
Gross Profit$952,000+78.9%
Operating Income-$511,000N/M
Operating Cash Flowderived-$1,122,000N/M
Margins · derived
Gross margin55.2%−2.9 pt vs Q3 2017
Operating margin-29.6%+26.9 pt vs Q3 2017
Net margin-32.8%+36.2 pt vs Q3 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $1.72M | $916.00K | $475.00K | $320.00K |
| Net Income | -$566.00K | -$632.00K | -$706.00K | -$581.00K |
| EPS Diluted | -$0.08 | -$0.01 | -$0.01 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR